JP2018500913A5 - - Google Patents

Download PDF

Info

Publication number
JP2018500913A5
JP2018500913A5 JP2017534913A JP2017534913A JP2018500913A5 JP 2018500913 A5 JP2018500913 A5 JP 2018500913A5 JP 2017534913 A JP2017534913 A JP 2017534913A JP 2017534913 A JP2017534913 A JP 2017534913A JP 2018500913 A5 JP2018500913 A5 JP 2018500913A5
Authority
JP
Japan
Prior art keywords
protein
nucleic acid
cell
cells
rnp
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017534913A
Other languages
English (en)
Japanese (ja)
Other versions
JP7278027B2 (ja
JP2018500913A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/013113 external-priority patent/WO2016115179A1/en
Publication of JP2018500913A publication Critical patent/JP2018500913A/ja
Publication of JP2018500913A5 publication Critical patent/JP2018500913A5/ja
Priority to JP2021087763A priority Critical patent/JP2021129584A/ja
Application granted granted Critical
Publication of JP7278027B2 publication Critical patent/JP7278027B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017534913A 2015-01-12 2016-01-12 マイクロ流体送達による遺伝子編集 Active JP7278027B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2021087763A JP2021129584A (ja) 2015-01-12 2021-05-25 マイクロ流体送達による遺伝子編集

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562102347P 2015-01-12 2015-01-12
US62/102,347 2015-01-12
PCT/US2016/013113 WO2016115179A1 (en) 2015-01-12 2016-01-12 Gene editing through microfluidic delivery

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021087763A Division JP2021129584A (ja) 2015-01-12 2021-05-25 マイクロ流体送達による遺伝子編集

Publications (3)

Publication Number Publication Date
JP2018500913A JP2018500913A (ja) 2018-01-18
JP2018500913A5 true JP2018500913A5 (enExample) 2019-02-28
JP7278027B2 JP7278027B2 (ja) 2023-05-19

Family

ID=56406306

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2017534913A Active JP7278027B2 (ja) 2015-01-12 2016-01-12 マイクロ流体送達による遺伝子編集
JP2021087763A Pending JP2021129584A (ja) 2015-01-12 2021-05-25 マイクロ流体送達による遺伝子編集

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2021087763A Pending JP2021129584A (ja) 2015-01-12 2021-05-25 マイクロ流体送達による遺伝子編集

Country Status (6)

Country Link
US (2) US11125739B2 (enExample)
EP (1) EP3245294A4 (enExample)
JP (2) JP7278027B2 (enExample)
CN (1) CN107250373A (enExample)
AU (1) AU2016206870B2 (enExample)
WO (1) WO2016115179A1 (enExample)

Families Citing this family (87)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6261500B2 (ja) 2011-07-22 2018-01-17 プレジデント アンド フェローズ オブ ハーバード カレッジ ヌクレアーゼ切断特異性の評価および改善
BR112014009346B1 (pt) * 2011-10-17 2020-09-15 Massachusetts Institute Of Technology Entrega intracelular
US20150044192A1 (en) 2013-08-09 2015-02-12 President And Fellows Of Harvard College Methods for identifying a target site of a cas9 nuclease
KR102243597B1 (ko) 2013-08-16 2021-04-26 메사추세츠 인스티튜트 오브 테크놀로지 세포로의 선택적 물질 전달
US9359599B2 (en) 2013-08-22 2016-06-07 President And Fellows Of Harvard College Engineered transcription activator-like effector (TALE) domains and uses thereof
US9228207B2 (en) 2013-09-06 2016-01-05 President And Fellows Of Harvard College Switchable gRNAs comprising aptamers
US9322037B2 (en) 2013-09-06 2016-04-26 President And Fellows Of Harvard College Cas9-FokI fusion proteins and uses thereof
US9737604B2 (en) 2013-09-06 2017-08-22 President And Fellows Of Harvard College Use of cationic lipids to deliver CAS9
US9068179B1 (en) 2013-12-12 2015-06-30 President And Fellows Of Harvard College Methods for correcting presenilin point mutations
US10077453B2 (en) 2014-07-30 2018-09-18 President And Fellows Of Harvard College CAS9 proteins including ligand-dependent inteins
CN107109362A (zh) 2014-10-31 2017-08-29 麻省理工学院 递送生物分子至免疫细胞
CN107002089B (zh) 2014-11-14 2021-09-07 麻省理工学院 化合物和组合物向细胞中的破坏和场实现的递送
WO2016115179A1 (en) 2015-01-12 2016-07-21 Massachusetts Institute Of Technology Gene editing through microfluidic delivery
WO2017008063A1 (en) 2015-07-09 2017-01-12 Massachusetts Institute Of Technology Delivery of materials to anucleate cells
US11613759B2 (en) 2015-09-04 2023-03-28 Sqz Biotechnologies Company Intracellular delivery of biomolecules to cells comprising a cell wall
EP3365356B1 (en) 2015-10-23 2023-06-28 President and Fellows of Harvard College Nucleobase editors and uses thereof
JP7033535B2 (ja) * 2016-01-12 2022-03-10 スクイーズ バイオテクノロジーズ カンパニー 複合体の細胞内送達
US20190275520A1 (en) 2016-03-31 2019-09-12 Massachusetts Institute Of Technology Flow-through microfluidic methods and devices featuring membrane-perturbing surface interactions for intracellular delivery
AU2017259987B2 (en) 2016-05-03 2023-10-19 Sqz Biotechnologies Company Intracellular delivery of biomolecules to induce tolerance
WO2018022634A1 (en) * 2016-07-26 2018-02-01 The General Hospital Corporation Variants of crispr from prevotella and francisella 1 (cpf1)
JP7231935B2 (ja) 2016-08-03 2023-03-08 プレジデント アンド フェローズ オブ ハーバード カレッジ アデノシン核酸塩基編集因子およびそれらの使用
EP3497214B1 (en) 2016-08-09 2023-06-28 President and Fellows of Harvard College Programmable cas9-recombinase fusion proteins and uses thereof
US11999931B2 (en) 2016-08-20 2024-06-04 The Regents Of The University Of California High-throughput system and method for the temporary permeabilization of cells
WO2018039438A1 (en) 2016-08-24 2018-03-01 President And Fellows Of Harvard College Incorporation of unnatural amino acids into proteins using base editing
US20190203230A1 (en) * 2016-09-28 2019-07-04 Novartis Ag Porous membrane-based macromolecule delivery system
US11242542B2 (en) 2016-10-07 2022-02-08 Integrated Dna Technologies, Inc. S. pyogenes Cas9 mutant genes and polypeptides encoded by same
KR102606680B1 (ko) 2016-10-07 2023-11-27 인티그레이티드 디엔에이 테크놀로지스 아이엔씨. S. 피오게네스 cas9 돌연변이 유전자 및 이에 의해 암호화되는 폴리펩티드
EP3526320A1 (en) 2016-10-14 2019-08-21 President and Fellows of Harvard College Aav delivery of nucleobase editors
CN110088286B (zh) * 2016-10-21 2024-01-02 新加坡科技研究局 用于细胞内递送物质的装置、系统和方法
CA3042179A1 (en) 2016-10-31 2018-05-03 Seattle Children's Hospital (dba Seattle Children's Research Institute) Method for treating autoimmune disease using cd4 t-cells with engineered stabilization of expression of endogenous foxp3 gene
US11136567B2 (en) * 2016-11-22 2021-10-05 Integrated Dna Technologies, Inc. CRISPR/CPF1 systems and methods
WO2018111947A1 (en) 2016-12-12 2018-06-21 Integrated Dna Technologies, Inc. Genome editing enhancement
US10745677B2 (en) 2016-12-23 2020-08-18 President And Fellows Of Harvard College Editing of CCR5 receptor gene to protect against HIV infection
JP6994730B2 (ja) * 2016-12-26 2022-02-04 独立行政法人酒類総合研究所 ゲノム編集タンパク質の直接導入による糸状菌ゲノム編集方法
WO2018165504A1 (en) 2017-03-09 2018-09-13 President And Fellows Of Harvard College Suppression of pain by gene editing
WO2018165631A1 (en) 2017-03-09 2018-09-13 President And Fellows Of Harvard College Cancer vaccine
KR20190127797A (ko) 2017-03-10 2019-11-13 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 시토신에서 구아닌으로의 염기 편집제
KR20240116572A (ko) 2017-03-23 2024-07-29 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 핵산 프로그램가능한 dna 결합 단백질을 포함하는 핵염기 편집제
EP3612551B1 (en) 2017-04-21 2024-09-04 The General Hospital Corporation Variants of cpf1 (cas12a) with altered pam specificity
US11560566B2 (en) 2017-05-12 2023-01-24 President And Fellows Of Harvard College Aptazyme-embedded guide RNAs for use with CRISPR-Cas9 in genome editing and transcriptional activation
CA3102054A1 (en) 2017-06-05 2018-12-13 Fred Hutchinson Cancer Research Center Genomic safe harbors for genetic therapies in human stem cells and engineered nanoparticles to provide targeted genetic therapies
WO2019023680A1 (en) 2017-07-28 2019-01-31 President And Fellows Of Harvard College METHODS AND COMPOSITIONS FOR EVOLUTION OF BASIC EDITORS USING PHAGE-ASSISTED CONTINUOUS EVOLUTION (PACE)
CA3073448A1 (en) 2017-08-23 2019-02-28 The General Hospital Corporation Engineered crispr-cas9 nucleases with altered pam specificity
EP3676376B1 (en) 2017-08-30 2025-01-15 President and Fellows of Harvard College High efficiency base editors comprising gam
CN111757937A (zh) 2017-10-16 2020-10-09 布罗德研究所股份有限公司 腺苷碱基编辑器的用途
WO2019118949A1 (en) 2017-12-15 2019-06-20 The Broad Institute, Inc. Systems and methods for predicting repair outcomes in genetic engineering
WO2019126146A1 (en) 2017-12-19 2019-06-27 Xcell Biosciences, Inc. Methods of modulating cell phenotype by way of regulating the gaseous environment
CA3089279A1 (en) 2018-02-07 2019-08-15 Dana-Farber Cancer Institute, Inc. Cell-permeable stapled peptide modules for cellular delivery
US20210000895A1 (en) * 2018-03-01 2021-01-07 Rhode Island Hospital Exosome targeting of cd4+ expressing cells
EP3556845A1 (en) 2018-04-20 2019-10-23 Cellix Limited A method and device for transfecting cells
JP7575950B2 (ja) 2018-04-27 2024-10-31 シアトル チルドレンズ ホスピタル ディー/ビー/エイ シアトル チルドレンズ リサーチ インスティテュート 遺伝子編集されたcd34+細胞におけるfoxp3の発現
US12157760B2 (en) 2018-05-23 2024-12-03 The Broad Institute, Inc. Base editors and uses thereof
CN108728330A (zh) * 2018-06-19 2018-11-02 东台德缘生物科技有限公司 一种用于哺乳动物细胞基因编辑载体构建的试剂盒
US20210388390A1 (en) * 2018-10-04 2021-12-16 Sqz Biotechnologies Company Intracellular delivery of biomolecules to enhance antigen presenting cell function
US12281338B2 (en) 2018-10-29 2025-04-22 The Broad Institute, Inc. Nucleobase editors comprising GeoCas9 and uses thereof
CN109666662A (zh) * 2018-12-12 2019-04-23 广州普世利华科技有限公司 新型ScCas12a在核酸检测方面的应用
CN109680053A (zh) * 2018-12-12 2019-04-26 广州普世利华科技有限公司 新型SsCas12a蛋白在核酸检测方面的应用
CN109593743A (zh) * 2018-12-12 2019-04-09 广州普世利华科技有限公司 新型CRISPR/ScCas12a蛋白及其制备方法
JP2022513490A (ja) * 2018-12-16 2022-02-08 フィジーン、エルエルシー 遺伝子編集線維芽細胞の治療的使用
WO2020154500A1 (en) 2019-01-23 2020-07-30 The Broad Institute, Inc. Supernegatively charged proteins and uses thereof
SG11202109333SA (en) 2019-02-28 2021-09-29 Sqz Biotechnologies Co Delivery of biomolecules to pbmcs to modify an immune response
MX2021011426A (es) 2019-03-19 2022-03-11 Broad Inst Inc Metodos y composiciones para editar secuencias de nucleótidos.
AU2020253023B2 (en) 2019-03-29 2022-07-14 F. Hoffmann-La Roche Ag Method for the generation of an FcRn expressing cell by targeted integration of multiple expression cassettes in a defined organization
KR20210149791A (ko) 2019-04-08 2021-12-09 에스큐지 바이오테크놀로지스 컴퍼니 페이로드를 세포 내로 전달하기 위한 시스템에서 이용하기 위한 카트리지
US12465912B2 (en) 2019-04-11 2025-11-11 The Chinese University Of Hong Kong Systems and methods for controlled membrane disruption
EP3956349A1 (en) 2019-04-17 2022-02-23 The Broad Institute, Inc. Adenine base editors with reduced off-target effects
US12473522B2 (en) 2019-06-12 2025-11-18 Cellfe, Inc. Methods and systems for cell labeling and imaging
EP4038190A1 (en) 2019-10-03 2022-08-10 Artisan Development Labs, Inc. Crispr systems with engineered dual guide nucleic acids
US12435330B2 (en) 2019-10-10 2025-10-07 The Broad Institute, Inc. Methods and compositions for prime editing RNA
MX2022005817A (es) * 2019-11-13 2022-06-08 Crispr Therapeutics Ag Metodos de fabricacion de linfocitos t-car.
BR112022009152A2 (pt) * 2019-11-13 2022-07-26 Crispr Therapeutics Ag Processo de fabricação para preparar células t expressando receptores de antígenos quiméricos
EP4065701A4 (en) 2019-11-27 2023-11-29 Danmarks Tekniske Universitet CONSTRUCTS, COMPOSITIONS AND METHODS THEREOF WITH IMPROVED GENOMEDITING EFFICIENCY AND SPECIFICITY
EP4093864A4 (en) 2020-01-24 2024-04-10 The General Hospital Corporation Unconstrained genome targeting with near-pamless engineered crispr-cas9 variants
WO2021151085A2 (en) 2020-01-24 2021-07-29 The General Hospital Corporation Crispr-cas enzymes with enhanced on-target activity
WO2021213479A1 (zh) * 2020-04-22 2021-10-28 复星凯特生物科技有限公司 Shp2特异性失活突变蛋白及其在car-t治疗中应用
MX2022014008A (es) 2020-05-08 2023-02-09 Broad Inst Inc Métodos y composiciones para la edición simultánea de ambas cadenas de una secuencia de nucleótidos de doble cadena objetivo.
CA3201944A1 (en) 2020-11-18 2022-05-27 Cellfe, Inc. Methods and systems for mechanoporation-based payload delivery into biological cells
US12227729B2 (en) 2020-12-24 2025-02-18 Cellfe, Inc. Methods and systems for high-throughput cell processing
US12018240B2 (en) 2020-12-29 2024-06-25 Stemcell Technologies Canada Inc. High-throughput microfluidic chip having parallelized constrictions for perturbing cell membranes
WO2022182801A1 (en) 2021-02-25 2022-09-01 Artisan Development Labs, Inc. Compositions and methods for targeting, editing, or modifying genes
CA3218511A1 (en) * 2021-05-10 2022-11-17 Sqz Biotechnologies Company Methods for delivering genome editing molecules to the nucleus or cytosol of a cell and uses thereof
WO2022256448A2 (en) 2021-06-01 2022-12-08 Artisan Development Labs, Inc. Compositions and methods for targeting, editing, or modifying genes
CA3223311A1 (en) 2021-06-18 2022-12-22 Andrea BARGHETTI Compositions and methods for targeting, editing or modifying human genes
WO2023167882A1 (en) 2022-03-01 2023-09-07 Artisan Development Labs, Inc. Composition and methods for transgene insertion
EP4526884A2 (en) 2022-05-20 2025-03-26 Artisan Development Labs, Inc. Systems and methods for assessing risk of genome editing events
WO2024062138A1 (en) 2022-09-23 2024-03-28 Mnemo Therapeutics Immune cells comprising a modified suv39h1 gene
EP4619534A2 (en) * 2022-11-16 2025-09-24 Mammoth Biosciences, Inc. Effector proteins, compositions, systems and methods of use thereof

Family Cites Families (125)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2502621C3 (de) 1975-01-23 1978-09-14 Kernforschungsanlage Juelich Gmbh, 5170 Juelich Messung elastischer und dielektrischer Eigenschaften der Membran lebender Zellen
US4376634A (en) 1980-05-30 1983-03-15 Mallinckrodt, Inc. Assay kit having syringe, dilution device and reagents within sealed container
US4478824A (en) 1983-08-08 1984-10-23 Franco Robert S Method for altering red blood cell function and survival
FR2569477B1 (fr) 1984-08-24 1987-01-02 Descartes Universite Rene Appareil et procede pour la determination de la deformabilite des globules rouges du sang
JP2720161B2 (ja) 1988-02-01 1998-02-25 株式会社アドバンス 細胞変形能測定装置
JP2685544B2 (ja) 1988-11-11 1997-12-03 株式会社日立製作所 血液フィルタおよび血液検査方法並びに血液検査装置
JP2532707B2 (ja) 1990-03-08 1996-09-11 佑二 菊池 血液回路及びこれを用いた血液測定装置及び血液測定方法
JPH05506233A (ja) 1990-04-24 1993-09-16 フラスタット・ピーティーワイ・リミテッド 赤血球の表面に結合した抗原を含むワクチン
US5658892A (en) 1993-01-15 1997-08-19 The General Hospital Corporation Compound delivery using high-pressure impulse transients
US6218166B1 (en) 1994-12-09 2001-04-17 John Wayne Cancer Institute Adjuvant incorporation into antigen carrying cells: compositions and methods
AU720201B2 (en) 1995-03-08 2000-05-25 Scripps Research Institute, The Antigen presenting system and methods for activation of T-cells
US6051409A (en) * 1995-09-25 2000-04-18 Novartis Finance Corporation Method for achieving integration of exogenous DNA delivered by non-biological means to plant cells
US6133503A (en) * 1995-10-31 2000-10-17 The Regents Of The University Of California Mammalian artificial chromosomes and methods of using same
DE69626853T2 (de) 1995-12-04 2004-02-19 Puget Sound Blood Center And Programm, Seattle Nicht-immunogene Blutplättchen und rote Blutzellen enthaltende Zubereitungen
BR9708387A (pt) 1996-03-28 2000-01-04 Genitrix Llc Processo para vacinação de um mamìfero a um antìgeno selecionado, células patogênica e hospedeira, composição de vacina, ácido nucleico, e, opsonina engenheirada.
US5885470A (en) 1997-04-14 1999-03-23 Caliper Technologies Corporation Controlled fluid transport in microfabricated polymeric substrates
EP0882448B1 (en) 1997-05-05 2005-01-12 DIDECO S.r.l. Method of encapsulating biologically active agents within erythrocytes and apparatus therefor
US5842787A (en) 1997-10-09 1998-12-01 Caliper Technologies Corporation Microfluidic systems incorporating varied channel dimensions
US20050019921A1 (en) 2001-11-27 2005-01-27 Orwar Owe E. Method for combined sequential agent delivery and electroporation for cell structures and use thereof
SE9704076D0 (sv) 1997-11-06 1997-11-06 Holdingbolaget Vid Goeteborgs Method for permeabilisation of cell structures and use thereof
GB9816583D0 (en) 1998-07-31 1998-09-30 Univ Ulster Nucleic acid carrier
WO2000078920A1 (en) 1999-06-21 2000-12-28 The General Hospital Corporation Methods and devices for cell culturing and organ assist systems
JP2002325572A (ja) 2000-12-25 2002-11-12 Univ Osaka 外来物質の導入方法
AU2002252073A1 (en) 2001-02-22 2002-09-12 The Scepens Eye Research Institute, Inc. Tolerogenic antigen presenting cells and in treating immune-inflammatory conditions
WO2003020039A1 (en) 2001-08-28 2003-03-13 Rush-Presbyterian-St. Luke's Medical Center Immune tolerance to predetermined antigens
US20030133922A1 (en) 2002-01-15 2003-07-17 Kasha John R. Oral tolerance using allogeneic platelets in ITP
WO2003104788A1 (ja) 2002-06-05 2003-12-18 松下電器産業株式会社 細胞外電位測定デバイスおよびその製造方法
GB0214528D0 (en) 2002-06-24 2002-08-07 Univ Aberdeen Materials and methods for induction of immune tolerance
CA2513072A1 (en) 2003-01-09 2004-07-29 Invitrogen Corporation Cellular delivery and activation polypeptide-nucleic acid complexes
US20060134067A1 (en) 2003-02-18 2006-06-22 Maxcyte, Inc. Loading of cells with antigens by electroporation
US7968335B2 (en) 2004-06-17 2011-06-28 Ken Nakata Cell culturing method using biomechanical stimulation loading and system therefor
JP4669876B2 (ja) 2004-07-27 2011-04-13 ディーエスエム アイピー アセッツ ビー.ブイ. カーボンナノチューブ/超高分子量ポリエチレン複合繊維を製造するための方法
FR2873925B1 (fr) 2004-08-05 2006-10-13 Erytech Pharma Soc Par Actions Procede et dispositif de lyse-rescellement pour l'incorporation de principe actif notamment asparaginase ou inositol hexaphosphate, dans des erythrocytes
ES2350895T3 (es) 2004-08-19 2011-01-28 University College Cardiff Consultants Limited Preparación de células t gamma delta humanas presentadoras de antígeno y su uso en inmunoterapia.
US20060134772A1 (en) 2004-11-18 2006-06-22 The Regents Of The University Of California System for locating cells and for cellular analysis
WO2006095330A2 (en) 2005-03-10 2006-09-14 Yeda Research And Development Co. Ltd. Methods and immunogenic cell preparations for treating antigen-associated diseases
US7704743B2 (en) 2005-03-30 2010-04-27 Georgia Tech Research Corporation Electrosonic cell manipulation device and method of use thereof
KR100760309B1 (ko) 2005-07-06 2007-10-05 한국과학기술원 미소필터를 이용한 미소입자 변형성 분석기
US7993821B2 (en) 2005-08-11 2011-08-09 University Of Washington Methods and apparatus for the isolation and enrichment of circulating tumor cells
US9005974B2 (en) 2005-12-09 2015-04-14 Academish Medisch Centrum Bij De Universiteit Van Amsterdam Means and methods for influencing the stability of cells
WO2007097934A2 (en) 2006-02-17 2007-08-30 Elusys Therapeutics, Inc. Methods and compositions for using erythrocytes as carriers for delivery of drugs
US8293524B2 (en) 2006-03-31 2012-10-23 Fluxion Biosciences Inc. Methods and apparatus for the manipulation of particle suspensions and testing thereof
US20070249038A1 (en) 2006-04-21 2007-10-25 Andrea Adamo Microfluidic device for single cell targeted operations
WO2008021465A2 (en) 2006-08-17 2008-02-21 Massachusetts Institute Of Technology Method and apparatus for microfluidic injection
WO2008098094A1 (en) 2007-02-06 2008-08-14 Network Biosystems, Inc. Devices and methods for the performance of miniaturized in vitro assays
US20080311140A1 (en) 2007-05-29 2008-12-18 Baylor College Of Medicine Antigen specific immunosuppression by dendritic cell therapy
US8841135B2 (en) 2007-06-20 2014-09-23 University Of Washington Biochip for high-throughput screening of circulating tumor cells
WO2008156021A1 (ja) 2007-06-21 2008-12-24 National University Corporation Nagoya University 細胞壁を備える細胞に外来物質を導入する方法
FR2919804B1 (fr) 2007-08-08 2010-08-27 Erytech Pharma Composition et vaccin therapeutique anti-tumoral
GB0718160D0 (en) 2007-09-18 2007-10-24 Medical Res Council Methods
EP2057998A1 (en) 2007-10-31 2009-05-13 Universitätsklinikum Hamburg-Eppendorf Use of modified cells for the treatment of multiple sclerosis
KR100891487B1 (ko) 2007-11-01 2009-04-01 한국과학기술원 미세유체제어기술 기반으로 한 난모세포 또는 난자의 핵제거 시스템
US20100249621A1 (en) 2007-11-28 2010-09-30 Konica Minolta Opto, Inc. Blood fluidity measurement apparatus and blood fluidity measurement method
US20090280518A1 (en) 2008-05-12 2009-11-12 Massachusetts Institute Of Technology System for high throughput measurement of mechanical properties of cells
JP2010002582A (ja) 2008-06-19 2010-01-07 Konica Minolta Business Technologies Inc 画像形成装置
JP5137129B2 (ja) 2008-07-23 2013-02-06 国立大学法人山口大学 血液細胞の力学的特性測定装置
US9115340B2 (en) 2008-08-08 2015-08-25 Agency For Science Technology & Research Microfluidic continuous flow device
US8211656B2 (en) 2008-08-13 2012-07-03 The Invention Science Fund I, Llc Biological targeting compositions and methods of using the same
US20110091973A1 (en) 2008-12-09 2011-04-21 Glaser Larry F Modified and fusion enhanced erythrocytes, cells and uses thereof
US9157550B2 (en) 2009-01-05 2015-10-13 The Board Of Trustees Of The University Of Illinois Microfluidic systems and methods
WO2010105135A1 (en) 2009-03-13 2010-09-16 Tufts University Methods, apparatuses, and kits for introducing genetic material into living cells
US9017991B2 (en) 2009-03-13 2015-04-28 Tufts University Methods tip assemblies and kits for introducing material into cells
SG174373A1 (en) 2009-03-20 2011-10-28 Agency Science Tech & Res Devices for separating cells and methods of using them
JP4849278B2 (ja) 2009-03-27 2012-01-11 セイコーエプソン株式会社 細胞処理デバイス、細胞処理カートリッジおよび体液処理システム
WO2010129671A2 (en) 2009-05-08 2010-11-11 Chauncey Sayre Method of and apparatus for changing one type of cell into another type of cell
GB0909754D0 (en) 2009-06-05 2009-07-22 Magnani Mauro Drug delivery systems
CA2765488C (en) * 2009-06-30 2018-01-02 Sangamo Biosciences, Inc. Rapid screening of biologically active nucleases and isolation of nuclease-modified cells
WO2011005799A2 (en) 2009-07-06 2011-01-13 Novartis Ag Self replicating rna molecules and uses thereof
KR101125060B1 (ko) 2009-07-22 2012-03-21 한국과학기술원 입자를 포획하는 미세유체 소자 및 이를 이용한 입자 포획 방법
US9364831B2 (en) 2009-08-08 2016-06-14 The Regents Of The University Of California Pulsed laser triggered high speed microfluidic switch and applications in fluorescent activated cell sorting
PT2493487T (pt) 2009-10-27 2016-11-08 Erytech Pharma Composição para induzir uma tolerância imunitária específica
DK2813572T3 (en) 2009-12-21 2016-08-01 Keygene Nv Improved techniques for transfection of protoplasts
CA2785390C (en) 2009-12-23 2016-02-09 Cytovera, Inc. A system and method for particle filtration
WO2011084882A2 (en) 2010-01-05 2011-07-14 Contrafect Corporation Methods and compositions for enhanced immunological therapy and targeting of gram-positive bacteria
US8844570B2 (en) * 2010-02-01 2014-09-30 California Institute Of Technology Generating binary states using a microfluidic channel
JP5704590B2 (ja) 2010-02-05 2015-04-22 国立大学法人東京農工大学 サイズ選択マイクロキャビティアレイを用いた循環腫瘍細胞の検出
AU2011222582B2 (en) 2010-03-04 2015-10-15 Massachusetts Institute Of Technology Microfluidics sorter for cell detection and isolation
WO2011119492A2 (en) 2010-03-22 2011-09-29 Massachusetts Institute Of Technology Methods and compositions related to the measurement of material properties
JP6343147B2 (ja) 2010-08-30 2018-06-13 プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ 狭窄病変および血栓溶解療法のための剪断による制御放出
AU2011333749B2 (en) 2010-11-25 2016-10-20 Imcyse Sa Immunogenic peptides for use in the prevention and/or treatment of infectious diseases, autoimmune diseases, immune responses to allofactors, allergic diseases, tumors, graft rejection and immune responses against viral vectors used for gene therapy or gene vaccination
EP2665540A1 (en) 2011-01-19 2013-11-27 The University of British Columbia Apparatus and method for particle separation
EP2678434B1 (en) * 2011-02-25 2018-11-07 Recombinetics, Inc. Genetically modified animals and methods for making the same
CA2828110C (en) 2011-02-28 2020-03-31 President And Fellows Of Harvard College Cell culture system
EP2714884B1 (en) 2011-05-27 2019-08-21 The University Of British Columbia Microfluidic cell trap and assay apparatus for high-throughput analysis
MX2013013243A (es) 2011-07-05 2014-05-30 Sotio As Medios y metodos para activar la inmunoterapia celular del cancer utilizando celulas cancerosas destruidas mediante presion hidrostatica y celulas dendriticas.
US20130065314A1 (en) 2011-08-25 2013-03-14 Phytocentric Biotech Inc. Algal transformation systems, compositions and methods
BR112014009346B1 (pt) * 2011-10-17 2020-09-15 Massachusetts Institute Of Technology Entrega intracelular
US20150147276A1 (en) 2012-06-07 2015-05-28 President And Fellows Of Harvard College Nanotherapeutics for drug targeting
US9255245B2 (en) 2012-07-03 2016-02-09 Agilent Technologies, Inc. Sample probes and methods for sampling intracellular material
WO2014065596A1 (en) * 2012-10-23 2014-05-01 Toolgen Incorporated Composition for cleaving a target dna comprising a guide rna specific for the target dna and cas protein-encoding nucleic acid or cas protein, and use thereof
CN102925337B (zh) 2012-11-08 2014-06-18 武汉友芝友生物制药有限公司 一种微流体细胞捕获芯片及其制备方法
US8697359B1 (en) * 2012-12-12 2014-04-15 The Broad Institute, Inc. CRISPR-Cas systems and methods for altering expression of gene products
GB201300049D0 (en) 2013-01-03 2013-02-20 Transimmune Ag Method for obtaining immuno-stimulatory dendritic cells
GB201300052D0 (en) 2013-01-03 2013-02-20 Transimmune Ag Method for obtaining immuno-suppressive dendritic cells
WO2014120956A1 (en) 2013-01-30 2014-08-07 Asta Fluidic Technologies, Inc. Microfluidic-based fetal red blood cell detection
US9725709B2 (en) 2013-03-12 2017-08-08 OpenCell Technologies, Inc. Intracellular delivery and transfection methods and devices
WO2014151888A1 (en) 2013-03-15 2014-09-25 The Regents Of The University Of California High-throughput cargo delivery into live cells using photothermal platforms
KR20140115560A (ko) 2013-03-21 2014-10-01 인하대학교 산학협력단 기계적 스트레스를 이용한 단세포 생물체 개질 방법 및 이에 사용되는 장치
CA3185368A1 (en) 2013-04-03 2014-10-09 Memorial Sloan-Kettering Cancer Center Effective generation of tumor-targeted t cells derived from pluripotent stem cells
KR101508974B1 (ko) 2013-05-14 2015-04-07 한국과학기술연구원 종양 세포의 검출장치 및 검출방법
KR102243597B1 (ko) 2013-08-16 2021-04-26 메사추세츠 인스티튜트 오브 테크놀로지 세포로의 선택적 물질 전달
CA2927947A1 (en) 2013-10-22 2015-04-30 Cellanyx Diagnostics, Llc Systems, devices and methods for microfluidic culturing, manipulation and analysis of tissues and cells
US10137673B2 (en) 2013-12-31 2018-11-27 Canon U.S. Life Sciences, Inc. Methods and systems for continuous flow cell lysis in a microfluidic device
RU2736495C2 (ru) 2014-04-01 2020-11-17 Рубиус Терапьютикс, Инк. Способ и композиции для иммуномодуляции
SG10201809157VA (en) 2014-04-18 2018-11-29 Editas Medicine Inc Crispr-cas-related methods, compositions and components for cancer immunotherapy
US10947526B2 (en) 2014-07-03 2021-03-16 Massachusetts Institute Of Technology Microfluidic assay for rapid optimization of cell electroporation
CN107109362A (zh) 2014-10-31 2017-08-29 麻省理工学院 递送生物分子至免疫细胞
CN107002089B (zh) 2014-11-14 2021-09-07 麻省理工学院 化合物和组合物向细胞中的破坏和场实现的递送
US9744533B2 (en) 2014-12-10 2017-08-29 Berkeley Lights, Inc. Movement and selection of micro-objects in a microfluidic apparatus
JP6367493B2 (ja) 2015-01-07 2018-08-01 インディー.インコーポレイテッド 機械的及び流体力学的マイクロ流体形質移入の方法ならびにそのための装置
WO2016115179A1 (en) 2015-01-12 2016-07-21 Massachusetts Institute Of Technology Gene editing through microfluidic delivery
WO2016183482A1 (en) 2015-05-13 2016-11-17 Rubius Therapeutics, Inc. Membrane-receiver complex therapeutics
GB201513278D0 (en) 2015-07-03 2015-09-09 Transimmune Ag And Yale University Device and method for obtaining immunostimulatory antigen-presenting cells
WO2017008063A1 (en) 2015-07-09 2017-01-12 Massachusetts Institute Of Technology Delivery of materials to anucleate cells
US11613759B2 (en) 2015-09-04 2023-03-28 Sqz Biotechnologies Company Intracellular delivery of biomolecules to cells comprising a cell wall
US20190382796A1 (en) 2015-09-04 2019-12-19 Sqz Biotechnologies Company Intracellular delivery of biomolecules mediated by a surface with pores
AU2016374643B2 (en) 2015-12-22 2023-12-14 Sangui Bio Pty. Ltd Therapeutic methods using erythrocytes
CN115969987A (zh) 2016-01-11 2023-04-18 鲁比厄斯治疗法股份有限公司 与免疫适应症的多模式治疗性细胞体系有关的组合物和方法
JP7033535B2 (ja) 2016-01-12 2022-03-10 スクイーズ バイオテクノロジーズ カンパニー 複合体の細胞内送達
AU2017259987B2 (en) 2016-05-03 2023-10-19 Sqz Biotechnologies Company Intracellular delivery of biomolecules to induce tolerance
US20210138050A1 (en) 2016-05-03 2021-05-13 Sqz Biotechnologies Company Intracellular delivery of biomolecules to induce tolerance
US20170326213A1 (en) 2016-05-16 2017-11-16 Augusta University Research Institute, Inc. Protein-Coupled Red Blood Cell Compositions and Methods of Their Use
CN106244543A (zh) 2016-07-29 2016-12-21 北京时合生物科技有限公司 一种pbmc体外诱导分化成为树突状细胞的方法
EP3538269A4 (en) 2016-11-08 2020-07-01 Georgia Tech Research Corporation METHODS OF INTRACELLULAR CONVECTION ADMINISTRATION
US20230130686A1 (en) 2021-10-25 2023-04-27 Massachusetts Institute Of Technology Devices and systems for delivery of materials to cells

Similar Documents

Publication Publication Date Title
JP2018500913A5 (enExample)
WO2019135816A3 (en) Novel nucleic acid modifiers
US12385083B2 (en) Methods of using master / copy arrays for spatial detection
BR112021012665A2 (pt) Polipeptídeos úteis para edição de genes e métodos de uso
CN110546495B (zh) 用于基因组编辑t细胞的选择和传代的方法
US12221720B2 (en) Methods for determining spatial and temporal gene expression dynamics during adult neurogenesis in single cells
Vu et al. Gold nanoparticle effects in polymerase chain reaction: favoring of smaller products by polymerase adsorption
JP2021121202A (ja) 初代造血細胞におけるタンパク質送達
JP2021129584A (ja) マイクロ流体送達による遺伝子編集
WO2017004279A3 (en) Compositions comprising nucleic acids and methods of using the same
WO2017070632A3 (en) Nucleobase editors and uses thereof
Hahn et al. Extrusion of RNA from a DNA-origami-based nanofactory
WO2017216771A3 (en) Crispr-cas system, materials and methods
CN104805078A (zh) 用于高效基因组编辑的rna分子的设计、合成及其应用
JP2015503535A5 (enExample)
JP2017533702A5 (enExample)
RU2018101666A (ru) Новые ферменты и системы crispr
EP4180526A3 (en) Composition for cleaving a target dna comprising a guide rna specific for the target dna and cas protein-encoding nucleic acid or cas protein, and use thereof
WO2015157579A3 (en) Enhanced nucleic acid constructs for eukaryotic gene expression
WO2005111240A3 (en) Field-switch sequencing
WO2019090160A3 (en) Compositions and methods of use thereof for the treatment of duchenne muscular dystrophy
US11427861B2 (en) Methods for identifying and modulating co-occurant cellular phenotypes
JP2018530530A5 (enExample)
Dai et al. Innovative Precision Gene‐Editing Tools in Personalized Cancer Medicine
US20250237605A1 (en) Living biosensors